These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9382965)

  • 1. Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis.
    Assy N; Hochberg Z; Amit T; Shen-Orr Z; Enat R; Baruch Y
    J Hepatol; 1997 Nov; 27(5):796-802. PubMed ID: 9382965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis.
    Assy N; Hochberg Z; Enat R; Baruch Y
    Dig Dis Sci; 1998 Jun; 43(6):1317-21. PubMed ID: 9635625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of parenteral nutrition without and with growth hormone on growth hormone/insulin-like growth factor-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis.
    Cao J; Luo SM; Liang L; Lai J
    JPEN J Parenter Enteral Nutr; 2007; 31(6):496-501. PubMed ID: 17947606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
    Wu YL; Ye J; Zhang S; Zhong J; Xi RP
    World J Gastroenterol; 2004 Sep; 10(18):2740-3. PubMed ID: 15309731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
    Liang LJ; Luo SM; Hu WJ
    Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):697-701. PubMed ID: 16008955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin-like growth factor binding protein 3 ternary complex is reduced in cirrhosis.
    Ottesen LH; Bendtsen F; Flyvbjerg A
    Liver; 2001 Oct; 21(5):350-6. PubMed ID: 11589772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis.
    Colakoğlu O; Taşkiran B; Colakoğlu G; Kizildağ S; Ari Ozcan F; Unsal B
    Turk J Gastroenterol; 2007 Dec; 18(4):245-9. PubMed ID: 18080921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3.
    Pirazzoli P; Cacciari E; De Iasio R; Pittalis MC; Dallacasa P; Zucchini S; Gualandi S; Salardi S; David C; Boschi S
    Arch Dis Child Fetal Neonatal Ed; 1997 Sep; 77(2):F100-4. PubMed ID: 9377129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of urinary insulin-like growth factors (IGFs) and IGF binding protein 3 in healthy volunteers before and after stimulation with recombinant human growth hormone.
    Tönshoff B; Blum WF; Vickers M; Kurilenko S; Mehls O; Ritz E
    Eur J Endocrinol; 1995 Apr; 132(4):433-7. PubMed ID: 7536090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis.
    Kratzsch J; Blum WF; Schenker E; Keller E
    Exp Clin Endocrinol Diabetes; 1995; 103(5):285-91. PubMed ID: 8536056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of free insulin-like growth factor-I measurement on the diagnosis and follow-up treatment of growth hormone-deficient adult patients.
    Musolino NR; Da Cunha Neto MB; Marino Júnior R; Giannella-Neto D; Bronstein MD
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):441-9. PubMed ID: 10468902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis.
    Donaghy AJ; Delhanty PJ; Ho KK; Williams R; Baxter RC
    J Hepatol; 2002 Jun; 36(6):751-8. PubMed ID: 12044524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S; Juul A; Becker U; Flyvbjerg A; Skakkebaek NE; Henriksen JH
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease.
    Toogood AA; Jones J; O'Neill PA; Thorner MO; Shalet SM
    Clin Endocrinol (Oxf); 1998 May; 48(5):569-76. PubMed ID: 9666868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment.
    Ferrante E; Giavoli C; Porretti S; Vassallo E; Ronchi CL; Lania AG; Beck-Peccoz P; Spada A
    Horm Metab Res; 2006 May; 38(5):352-5. PubMed ID: 16718634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.